 | • レポートコード：EMREFR13475 • 出版社/出版日：Expert Market Research / 2026年4月 • レポート形態：英語、PDF、150ページ • 納品方法：Eメール（納期：3日） • 産業分類：製薬 |
| Single User（1名様閲覧用） | ￥670,644 (USD4,299) | ▷ お問い合わせ |
| Five User（5名様閲覧用） | ￥904,644 (USD5,799) | ▷ お問い合わせ |
| Corporate License（閲覧人数無制限） | ￥1,091,844 (USD6,999) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 末梢神経損傷は、年間人口10万人あたり13～23人が罹患すると推定されています。手首より遠位の上肢の神経が最も頻繁に損傷を受け、男性の方がこの損傷を被る可能性が高くなっています。外傷や手術は、この損傷を引き起こす多くの原因のうちの2つです。治療法としては、外科的介入、神経固定術、および移植療法などが挙げられます。「末梢神経損傷の疫学予測レポート」では、この疾患の有病率、発生パターン、および関連する危険因子について詳細な分析を提供します。 末梢神経損傷の疫学予測レポートの調査範囲 Expert Market Researchの「末梢神経損傷の疫学予測レポート 2026-2035」は、末梢神経損傷の有病率および人口統計に関する包括的な情報を提供します。本レポートは、様々な集団における末梢神経損傷症例の将来の発症率および有病率を予測しています。本調査では、末梢神経損傷患者集団の主要な決定要因として、年齢、性別、および損傷の種類を網羅しています。本レポートは、経時的な末梢神経損傷の有病率の傾向を明らかにし、複数の変数に基づいて将来のトレンドを予測しています。 本レポートは、この疾患に関する包括的な概要に加え、8つの主要市場における末梢神経損傷の疫学に関する過去データおよび予測データを提供しています。 対象地域 米国 ドイツ フランス イタリア スペイン 英国 日本 インド 末梢神経損傷の理解：疾患の概要 末梢神経損傷とは、脳や脊髄以外の神経が損傷を受けることを指します。この種の損傷は、外傷、圧迫、あるいは糖尿病のような全身性疾患によって引き起こされることがよくあります。これらの神経は筋肉の動きを調節し、感覚情報を伝達しているため、損傷を受けると筋力低下、しびれ、痛み、あるいは機能喪失を引き起こす可能性があります。一般的な形態には、神経叢障害（神経叢の損傷）、多発性神経障害（複数の神経の損傷）、単発性神経障害（単一の神経の損傷）などがあります。損傷の部位と程度によって症状が決まります。この疾患の診断には、画像診断、神経伝導検査、および臨床検査が一般的に用いられます。 末梢神経損傷の疫学的視点 末梢神経損傷の疫学部門では、過去から現在に至るまでの患者数に関する情報に加え、8つの主要市場それぞれの予測動向を提供しています。Expert Market Researchは、幅広い研究を精査することで、末梢神経損傷の疫学的状況に関する現在および予測される動向を提示しています。さらに、本レポートでは、末梢神経損傷の診断済み患者数とその動向についても取り上げています。末梢神経損傷の詳細な疫学的セグメンテーションは、男性および女性の総有病症例数、ならびに異なる年齢層や患者層にわたる総診断症例数といった具体的なカテゴリーに分類されています。 年間100人あたり13～23件と推定される発生率から、末梢神経損傷は非常に一般的な外傷後遺症です。 ある研究によると、スポーツに関連する損傷の約0.5％が末梢神経損傷によるものであると報告されています。 欧州のレベルI外傷センターで実施された2022年の研究によると、外傷性神経損傷患者の平均年齢は43.2歳であった。外傷性神経損傷を呈した患者の73.5％を男性が占めた。対照的に、非外傷性患者の平均年齢は56.2歳であり、52.3％が女性であった。 年齢別末梢神経損傷の疫学的知見 2012年1月から2020年7月にかけて実施された研究によると、外傷センターで治療を受けた110,667人のデータが分析された。このうち、5,026人の患者が少なくとも1つの末梢神経損傷と診断された。内訳は、成人4,738人（94.3%）、18歳未満の小児および青年288人（5.7%）であった。患者の平均年齢は45.8歳で、標準偏差は18.6歳であった。24歳と56歳の年齢層で、発生率の2つのピークが観察された。 国別の末梢神経損傷の疫学セグメント 疫学セクションでは、米国、ドイツ、スペイン、イタリア、フランス、英国、日本、インドにおける末梢神経損傷の疫学データおよび調査結果も提供されている。 スポーツ傷害、外傷、糖尿病、自己免疫疾患、その他いくつかの感染症といった要因の違いにより、末梢神経損傷の疫学的状況は国によって異なる。ある研究によると、イングランドにおける末梢神経損傷の全国平均年間発生率は、人口10万人あたり11.2症例である。男性が末梢神経損傷（PNI）を患うリスクは、女性の少なくとも2倍高い。 末梢神経損傷：治療の概要 治療法は、末梢神経損傷の種類、程度、および部位に基づいて決定される。一般的な処置には、理学療法、安静、および抗炎症薬や鎮痛剤などの処方薬が含まれる。圧迫性損傷（手根管症候群など）の場合、副子による固定や作業環境の改善が有効である場合がある。重症または治療に反応しない損傷の場合、神経修復、移植、または除圧などの外科的処置が必要になることがあります。機能を回復させ、筋萎縮などの問題を回避するためには、リハビリテーションが不可欠です。早期診断と適切な管理により、回復の見込みは高まります。 |
Peripheral nerve injuries are estimated to affect 13–23 for every 100,000 people annually. Nerves in the upper limbs distal to the wrist are most frequently injured, and males are more likely to experience these injuries. Trauma and surgery are two of the many possible causes of these injuries. Surgical intervention, neurosynthesis, and graft treatments are available forms of treatment. The peripheral nerve injuries epidemiology forecast report will offer a detailed analysis of the condition’s prevalence, incidence patterns, and related risk factors.
Peripheral Nerve Injuries Epidemiology Forecast Report Coverage
Expert Market Research’s “Peripheral Nerve Injuries Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of peripheral nerve injuries. It projects the future incidence and prevalence rates of peripheral nerve injuries cases across various populations. The study covers age, gender, and type as major determinants of the peripheral nerve injuries population. The report highlights patterns in the prevalence of peripheral nerve injuries over time and projects future trends based on multiple variables.
The report provides a comprehensive overview of the disease, as well as historical and projected data on peripheral nerve injuries epidemiology in the 8 major markets.
Regions Covered
• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India
Peripheral Nerve Injuries Understanding: Disease Overview
Peripheral nerve injury involves damage to the nerves outside of the brain and spinal cord. This type of damage is frequently brought on by trauma, compression, or systemic diseases like diabetes. Damage to these nerves can result in weakness, numbness, pain, or loss of function since they regulate muscle movements and transmit sensory data. Common forms include plexopathy (injury to the nerve plexus), polyneuropathy (damage to several nerves), and mononeuropathy (damage to a single neuron). The location and extent of the injury determine the symptoms. Imaging, nerve conduction investigations, and clinical examination are commonly used to make the diagnosis of the condition.
Peripheral Nerve Injuries Epidemiology Perspective
The peripheral nerve injuries epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for peripheral nerve injuries epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for peripheral nerve injuries and their trends. The peripheral nerve injuries detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
• With an estimated incidence of 13 to 23 per 100 people annually, peripheral nerve damage is a very common trauma sequela.
• A study reported that approximately 0.5% of injuries related to sports are caused by peripheral nerve damage.
• A 2022 study conducted at the European Level I Trauma Center reported the condition had a mean age of 43.2 years. Men made up 73.5% of patients who presented with traumatic nerve injury. In contrast, non-traumatic patients had a mean age of 56.2 years and were 52.3% female.
Age-Based Peripheral Nerve Injuries Epidemiology Insights
According to a study conducted between January 2012 and July 2020, data from 110,667 individuals treated at a trauma center were analyzed. Among these, 5,026 patients were diagnosed with at least one peripheral nerve injury: 4,738 were adults (94.3%), while 288 were children and adolescents under the age of 18 (5.7%). The average age of the patients was 45.8 years, with a standard deviation of 18.6 years. Two incidence peaks were observed at the ages of 24 and 56.
Country-wise Peripheral Nerve Injuries Epidemiology Segment
The peripheral nerve injuries epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.
The epidemiology of peripheral nerve injuries varies between countries, owing to differences in factors such as sports injuries, trauma injury, diabetes, autoimmune diseases and several other infections. According to a study, the average annual national incidence of peripheral nerve injury in England is 11.2 cases per 100,000 people. The risk of suffering a PNI is at least twice as high for men.
Peripheral Nerve Injuries: Treatment Overview
The treatment is determined on the basis of the kind, extent, and location of peripheral nerve injuries. Conventional measures include physical therapy, rest, and prescription pharmaceuticals such as anti-inflammatory or painkillers. Splinting or ergonomic modifications may be beneficial in cases of compression (such as carpal tunnel syndrome). Surgical procedures including nerve repair, grafting, or decompression may be necessary for severe or nonresponsive injuries. To restore function and avoid problems like muscular atrophy, rehabilitation is essential. Recovery prospects are improved by early diagnosis and suitable management.
レポート目次01 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
02 Executive Summary
03 Peripheral Nerve Injuries Market Overview – 8 MM
3.1 Peripheral Nerve Injuries Market Historical Value (2019-2025)
3.2 Peripheral Nerve Injuries Market Forecast Value (2026-2035)
04 Peripheral Nerve Injuries Epidemiology Overview – 8 MM
4.1 Peripheral Nerve Injuries Epidemiology Scenario (2019-2025)
4.2 Peripheral Nerve Injuries Epidemiology Forecast (2026-2035)
05 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Peripheral Nerve Injuries
06 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
07 Epidemiology Scenario and Forecast – 8 MM (2019-2035)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Peripheral Nerve Injuries
7.4 Gender-Specific Cases of Peripheral Nerve Injuries
7.5 Type-Specific Cases of Peripheral Nerve Injuries
7.6 Age-Specific Cases of Peripheral Nerve Injuries
08 Epidemiology Scenario and Forecast: United States (2019-2035)
8.1 Assumptions and Rationale in the United States
8.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in the United States
8.3 Gender-Specific Cases of Peripheral Nerve Injuries in the United States
8.4 Type-Specific Cases of Peripheral Nerve Injuries in United States
8.5 Age-Specific Cases of Peripheral Nerve Injuries in the United States
09 Epidemiology Scenario and Forecast: United Kingdom (2019-2035)
9.1 Assumptions and Rationale in the United Kingdom
9.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in the United Kingdom
9.3 Gender-Specific Cases of Peripheral Nerve Injuries in the United Kingdom
9.4 Type-Specific Cases of Peripheral Nerve Injuries in United Kingdom
9.5 Age-Specific Cases of Peripheral Nerve Injuries in the United Kingdom
10 Epidemiology Scenario and Forecast: Germany (2019-2035)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in Germany
10.3 Gender-Specific Cases of Peripheral Nerve Injuries in Germany
10.4 Type-Specific Cases of Peripheral Nerve Injuries in Germany
10.5 Age-Specific Cases of Peripheral Nerve Injuries in Germany
11 Epidemiology Scenario and Forecast: France (2019-2035)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in France
11.3 Gender-Specific Cases of Peripheral Nerve Injuries in France
11.4 Type-Specific Cases of Peripheral Nerve Injuries in France
11.5 Age-Specific Cases of Peripheral Nerve Injuries in France
12 Epidemiology Scenario and Forecast: Italy (2019-2035)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in Italy
12.3 Gender-Specific Cases of Peripheral Nerve Injuries in Italy
12.4 Type-Specific Cases of Peripheral Nerve Injuries in Italy
12.5 Age-Specific Cases of Peripheral Nerve Injuries in Italy
13 Epidemiology Scenario and Forecast: Spain (2019-2035)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in Spain
13.3 Gender-Specific Cases of Peripheral Nerve Injuries in Spain
13.4 Type-Specific Cases of Peripheral Nerve Injuries in Spain
13.5 Age-Specific Cases of Peripheral Nerve Injuries in Spain
14 Epidemiology Scenario and Forecast: Japan (2019-2035)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in Japan
14.3 Gender-Specific Cases of Peripheral Nerve Injuries in Japan
14.4 Type-Specific Cases of Peripheral Nerve Injuries in Japan
14.5 Age-Specific Cases of Peripheral Nerve Injuries in Japan
15 Epidemiology Scenario and Forecast: India (2019-2035)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Peripheral Nerve Injuries in India
15.3 Gender-Specific Cases of Peripheral Nerve Injuries in India
15.4 Type-Specific Cases of Peripheral Nerve Injuries in India
15.5 Age-Specific Cases of Peripheral Nerve Injuries in India
16 Patient Journey
17 Treatment Challenges and Unmet Needs
18 Key Opinion Leaders (KOL) Insights
スターガルト病（STGD）の疫学予測：2026年～2035年 Stargardt disease (STGD) is the most prevalent childhood recessively inherited macular dystrophy. About 7% of all retinal degeneration is caused by STGD, which affects roughly 1 in 10,000 people. The illness typically first appears in early childhood or adolescence, though reports of a later onset h…- 自律神経失調症の市場規模、疫学、治療薬販売、パイプライン、地域別展望2025-2035 The dysautonomia market reached a value of USD 2.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 6.2 Billion by 2035, exhibiting a growth rate (CAGR) of 9.39% during 2025-2035. The dysautonomia market has …
- ムコ多糖症の疫学予測：2026年～2035年 Mucopolysaccharidosis is a rare congenital disorder with low birth incidence and prevalence, emphasizing the need for early diagnosis, specialized care, and ongoing surveillance to manage its global and national burden effectively. The mucopolysaccharidosis epidemiology forecast by Expert Market Res…
- 便失禁の疫学予測：2026年～2035年 Fecal incontinence remains a widely underrecognized and underreported condition with meaningful clinical and social implications. According to Isabelle Mack et al. (2023), about 1 in 12 adults worldwide suffers from FI, reflecting a substantial burden. The fecal incontinence epidemiology forecast by…
- スポーツニュートリションの日本市場（2026年-2035年） The Japan sports nutrition market was valued at USD 3.26 Billion in 2025. The market is expected to grow at a CAGR of 9.00% during the forecast period of 2026-2035 to reach a value of USD 7.72 Billion by 2035. Expanding participation in community marathons, corporate fitness programs, and government…